References
- Advocating Safety in Healthcare E-Sisters. (2022). Essure problems. https://www.ashesnonprofit.com/essure
- Applequist, J. (2016). Broadcast pharmaceutical advertising in the United States: Primetime pill pushers. Lexington Books.
- Bayer. (2018a). News release: Bayer reaffirms safety profile of Essure. https://www.bayer.com/en/file/35321/download?token=KMNuHS-b
- Bayer. (2018b). Bayer to voluntarily discontinue U.S. sales of Essure for business reasons. https://www.bayer.com/en/file/35331/download?token=CtHS6hzL
- Bayer. (2020). Essure permanent birth control. https://www.essure.com/
- Belluck, P., Kaplan, S., & Robbins, R. (2021). How an unproven Alzheimer’s drug got approved. https://www.nytimes.com/2021/07/19/health/alzheimers-drug-aduhelm-fda.html
- Blaikie, N. W. H. (2000). Designing social research: The logic of anticipation. Polity.
- Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706QP063OA
- Braun, V., & Clarke, V. (2020). One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qualitative Research in Psychology, 18(3), 328–352. https://doi.org/10.1080/14780887.2020.1769238
- Chavkin, S. (2019). The implant files sparked reform around the world. Here’s why we’re still reporting. https://www.icij.org/investigations/implant-files/the-implant-files-sparked-reform-from-around-the-world-heres-why-were-still-reporting/
- Cohen, E., & Kessler, A. (2018). CNN exclusive: Bayer paid doctors millions for questionable birth control device. https://www.cnn.com/2018/07/27/health/essure-bayer-doctor-payments-eprise/index.html
- Creswell, J., & Poth, C. N. (2017). Qualitative inquiry and research design: Choosing from among five approaches. Sage.
- Denker, K. J. (2021). Critical feminist theory: Giving voice and visibility to gendered experiences. In D. O. Braithwaite, & P. Schrodt (Eds.), Engaging theories in interpersonal communication: Multiple perspectives (3rd ed., pp. 233–245). Routledge. https://doi.org/10.4324/9781003195511
- Diamond, D. (2021). “I’m still not planning to get it”: FDA approval not swaying some vaccine holdouts. https://www.washingtonpost.com/health/2021/08/25/fda-approval-vaccine-holdouts/
- Dick, K. (Director), Ziering, A., & Herdy, A. (Producers) (2018). The bleeding edge [film]. Shark Island Productions.
- DrugWatch. (2022). Essure lawsuits. https://www.drugwatch.com/essure/lawsuits/
- Ebeling, M. (2011). ‘Get with the program!’: Pharmaceutical marketing, symptom checklists and self-diagnosis. Social Science & Medicine, 73(6), 825–832. https://doi.org/10.1016/j.socscimed.2011.05.054
- Facebook. (2022). Essure problems. https://www.facebook.com/groups/Essureproblems/
- Flemmen, A. B. (2018). Sensitizing concepts in action: Expanding the framework. In H. Leiulfsrud, & P. Sohlberg (Eds.), Concepts in action: Conceptual constructionism (pp. 79–94). Brill.
- Foucault, M. (1980). Power/knowledge: Selected interviews & other writings 1972–1977. Penguin Random House.
- Foucault, M., Dreyfus, H. L., & Rabinow, P. (1982). Michel foucault: Beyond structuralism and hermeneutics. Harvester Weatsheaf.
- Geyer, R. (2011). The politics of EU health policy and the case of direct-to-consumer advertising for prescription drugs. The British Journal of Politics and International Relations, 13(4), 586–602. https://doi.org/10.1111/j.1467-856X.2011.00460.x
- Grand View Research. (2022). U.S. medical device manufacturers market size, share, & trends analysis report by type, and segments forecasts, 2021–2028. https://www.grandviewresearch.com/industry-analysis/us-medical-device-manufacturers
- Guillemin, M., & Gillam, L. (2004). Ethics, reflexivity, and “ethically important moments” in research. Qualitative Inquiry, 10(2), 261–280. https://doi.org/10.1177/1077800403262360
- Hanisch, C. (1970). The personal is political. Notes from the second year: Women’s liberation, major writings of the radical feminists. Radical Feminism.
- Hintz, E. A. (2022). Childfree sterilization: A normative rhetorical theory analysis of paradoxical dilemmas encountered by childfree patients and their providers. Rhetoric of Health & Medicine, 5(3), 280–307. https://doi.org/10.5744/rhm.2022.50014
- Hubner, S., Maloney, C., Phillips, S. D., Doshi, P., Mugaga, J., Ssekitoleko, R. T., Mueller, J. L., & Fitzgerald, T. N. (2021). The evolving landscape of medical device regulation in east, central, and Southern Africa. Global Health: Science and Practice, 9(1), 136–148. https://doi.org/10.9745/GHSP-D-20-00578
- Institute of Medicine (US). (2011). Medical devices and the public's health: The FDA 510 (k) clearance process at 35 years. National Academies Press.
- Kavada, A., & Poell, T. (2021). From counterpublics to contentious publicness: Tracing the temporal, spatial, and material articulations of popular protest through social media. Communication Theory, 31(2), 190–208. https://doi.org/10.1093/ct/qtaa025
- Kinard, M., & Redberg, R. R. (2021). Is the FDA failing women? https://journalofethics.ama-assn.org/article/fda-failing-women/2021-09
- Lalani, C., Kunwar, E. M., Kinard, M., Dhruva, S. S., & Redberg, R. F. (2021). Reporting of death in US food and drug administration medical device adverse event reports in categories other than death. JAMA Internal Medicine, 181(9), 1217–1223. https://doi.org/10.1001/jamainternmed.2021.3942
- Lamph, S. (2012). Regulation of medical devices outside the European union. Journal of the Royal Society of Medicine, 105(1_suppl), 12–21. https://doi.org/10.1258/jrsm.2012.120037
- Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Sage.
- Llamas, M. (2021). How the FDA let women down. https://www.drugwatch.com/featured/fda-let-women-down/
- Manning, J., & Kunkel, A. (2013). Researching interpersonal relationships: Qualitative methods, studies, and analysis. Sage.
- Martinez, W. (2021). Attack of the clones: An examination and critique of FDA's medical device regulatory scheme. Tennessee Journal of Law and Policy, 15(2), 344–400. https://ir.law.utk.edu/tjlp/vol15/iss2/5
- Marx, K. (1867/2010). Capital: A critique of political economy. Pacific Publishing Studio.
- Moore, J. (2017). Where is the critical empirical interpersonal communication research? A roadmap for future inquiry into discourse and power. Communication Theory, 27(1), 1–20. https://doi.org/10.1111/comt.12107
- Moore, J., & Manning, J. (2019). What counts as critical interpersonal and family communication research? A review of an emerging field of inquiry Annals of the International Communication Association, 43(1), 40–57. https://doi.org/10.1080/23808985.2019.1570825
- N., Vivo. (2020). https://support.qsrinternational.com/s/.
- Obregón, R., & Tufte, T. (2017). Communication, social movements, and collective action: Toward a new research agenda in communication for development and social change. Journal of Communication, 67(5), 635–645. https://doi.org/10.1111/jcom.12332
- Piller, C. (2019). FDA enforcement actions plummet under Trump. https://www.science.org/content/article/exclusive-fda-enforcement-actions-plummet-under-trump
- Resnic, F. S., & Normand, S. L. T. (2012). Postmarketing surveillance of medical devices — filling in the gaps. New England Journal of Medicine, 366(10), 875–877. https://doi.org/10.1056/NEJMp1114865
- Sotirin, P. J., & Ellingson, L. L. (2018). Critical feminist family communication theory. In D. O. Braithwaite, E. A. Suter, & K. Floyd (Eds.), Engaging theories in family communication (2nd ed., pp. 110–121). Routledge.
- Suter, E. A. (2016). Introduction: Critical approaches to family communication research: Representation, critique, and praxis. Journal of Family Communication, 16(1), 1–8. https://doi.org/10.1080/15267431.2015.1111219
- Suter, E. A. (2018). The promise of contrapuntal and intersectional methods for advancing critical interpersonal and family communication research. Communication Monographs, 85(1), 123–139. https://doi.org/10.1080/03637751.2017.1375131
- Thompson, C. M., & Duerringer, C. M. (2020). Crying wolf: A thematic and critical analysis of why individuals contest family members’ health complaints. Communication Monographs, 87(3), 291–311. https://doi.org/10.1080/03637751.2019.1709127
- U.S. Food and Drug Administration. (2002). Summary of safety and effectiveness data: EssureTM system P020014. https://www.accessdata.fda.gov/cdrh_docs/pdf2/p020014b.pdf
- U.S. Food and Drug Administration. (2015a). Nonrulemaking docket: Labeling for permanent hysteroscopically-placed tubal implants intended for sterilization. https://www.regulations.gov/docket/FDA-2016-D-0435
- U.S. Food and Drug Administration. (2015b). From the manufacturers’ mouth to your ears: Direct to consumer advertising. https://www.fda.gov/drugs/special-features/manufacturers-mouth-your-ears-direct-consumer-advertising
- U.S. Food and Drug Administration. (2016). Labeling for permanent hysteroscopically-placed tubal implants intended for sterilization. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/labeling-permanent-hysteroscopically-placed-tubal-implants-intended-sterilization
- U.S. Food and Drug Administration. (2018). Medical device overview. https://www.fda.gov/industry/regulated-products/medical-device-overview
- U.S. Food and Drug Administration. (2019). Premarket approval (PMA). https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-approval-pma#overview
- U.S. Food and Drug Administration. (2020a). Overview of device regulation. https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/overview-device-regulation
- U.S. Food and Drug Administration. (2020b). Premarket notification 510(k). https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-notification-510k
- U.S. Food and Drug Administration. (2021a). Problems reported with Essure. https://www.fda.gov/medical-devices/essure-permanent-birth-control/problems-reported-essure
- U.S. Food and Drug Administration. (2021b). FDA activities related to Essure. https://www.fda.gov/medical-devices/essure-permanent-birth-control/fda-activities-related-essure
- Wong, J., & Tong, R. (2018). Handbook of medical device regulatory affairs in Asia. CRC Press.
- Wood, J. T. (2015). Critical feminist theories: Giving voice and visibility to women’s experiences in interpersonal relations. In D. O. Braithwaite, & P. Schrodt (Eds.), Engaging theories in interpersonal communication: Multiple perspectives (2nd ed., pp. 203–216). Sage.
- Zhang, S. (2015). How a Facebook group got the FDA to reconsider a type of birth control. https://www.wired.com/2015/09/facebook-group-got-fda-reconsider-type-birth-control/